Literature DB >> 14888515

Present status of therapy in myasthenia gravis.

N S SCHLEZINGER.   

Abstract

Entities:  

Keywords:  MYASTHENIA GRAVIS/therapy

Mesh：

Year:  1952        PMID： 14888515     DOI： 10.1001/jama.1952.02930070008003

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  6 in total

Review 1.  [ACTH AND CORTICOID TREATMENT OF NEUROLOGIC DISEASES].

Authors:  H BAMMER
Journal:  Dtsch Z Nervenheilkd       Date:  1963-07-10

2.  [Chemotherapy of myasthenia].

Authors:  H BAUER; O SCHMID
Journal:  Dtsch Z Nervenheilkd       Date:  1953

Review 3.  [The pathogenesis of myasthenia gravis as an immunological problem].

Authors:  J R Kalden
Journal:  Klin Wochenschr       Date:  1970-01-01

4.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

Review 5.  Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.

Authors:  Itay Lotan; Mark A Hellmann; Adi Wilf-Yarkoni; Israel Steiner
Journal:  J Neurol       Date:  2020-10-16       Impact factor: 6.682

6.  Corticotropin and cortisone in diseases of the nervous system.

Authors:  H H MERRITT
Journal:  Yale J Biol Med       Date:  1952-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.